Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsBertrand Routy, Laurence Zitvogel, Christophe Klein et al.|Science|2017Cited by 5.4k
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerLisa Derosa, Benjamin Besse, Bertrand Routy et al.|Nature Medicine|2022Cited by 637
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signallingA.T.Y. Ko, Éric Deutsch|Cell Death and Differentiation|2013Cited by 195
Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in CombinationPierre Mordant, Éric Deutsch|Molecular Cancer Therapeutics|2010Cited by 48
Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancerYohann Loriot, Éric Deutsch|Cell Death and Disease|2014Cited by 45